Comparison

RELA Peptide - middle region (AAP30371)

Item no. AAP30371
Manufacturer AVIVA Systems Biology
Amount 100 ug
Category
Type Peptides
Format Lyophilized powder
Applications WB
Specific against other
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias MGC131774, NFKB3
Similar products RELA
Available
Description
This is a synthetic peptide designed for use in combination with anti-RELA antibody (Catalog #: ARP30371_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Gene symbol
RELA
Protein size
551
Molecular weight
60kDa
Product format
Lyophilized powder
Gene id
5970
Reconstitution and storage
Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles.
Partner proteins
AES, BIRC3, CARM1, CCND1, CHEK1, CHUK, CREBBP, CREBBP, CXCL10, EGR1, EP300, EP300, FOS, IL8, ING4, JUN, NCOA3, NFKB1, NFKB1, NFKBIA, NFKBIA, NFKBIB, NFKBIB, SLC1A2, TERT, TLE1, AATF, ACTL6A, AES, AHR, AKAP8, APBA2, AR, BRCA1, BTK, BTRC, CALM1, CAMK4, CARM1, CDK9, CEBPB, CEBPD, CHEK1, CHUK, COMMD1, CREBBP, CSNK2A1, DDX1, DHX9, EGR1, EP300, ESR1, ETHE1, FAF1, FOS, FUS, GTF2B, HDAC1, HDAC2, HDAC3, HEXIM1, HMGA2, HMGB1, IKBKB, ING4, IRAK1BP1, IRF1, IRF2, IRF3, JUN, KAT2B, KPNA2, MAP2K6, MAP3K7, MAP3K8, MEN1, MST1R, MTPN, MYC, NCOA3, NCOR2, NFKB1, NFKB2, NFKBIA, NFKBIB, NFKBIE, NKRF, NKX2-1, NOTCH1, NR3C1, PARP1, PDCD11, PGR, PIAS1, PIAS3, PIN1, PML, POU2F1, PPARA, PPP1R13L, PPP2CA, PPP2R1B, PPP4C, PRKACA, PRKCZ, PRTN3, REL, RELA, RELB, REPS2, RFC1, RNF25, RPS6KA5, RXRA, SIRT1, SNIP1, SOCS1, SP1, SRF, STAT1, STAT3, STAT6, TAF1, TAF11, TAF4B, TAF6, TBK1, TBP, TERT, TNIP2, TP53BP1, TP53BP2, TRIB3, TRIP4, TSC22D3, TWIST1, UNC5CL, AES, AHR, AKAP8L, APBA2, ASCC1, ASCC2, ASCC3, BARD1, BRCA1, BTRC, CDK9, CEBPB, CEBPD, COMMD1, CREBBP, CSNK2A1, CSNK2A2, DHX9, EGR1, EP300, ETHE1, FOS, FUS, GTF2B, HDAC1, HDAC2, HDAC3, HEXIM1, HMGA2, HMGB1, Hdac1, ING4, IQGAP2, IRF2, IRF8, IRF9, ITGB3BP, JUN, KDM2A, KPNA2, MAP3K8, MEN1, MTPN, MYC, NCF1, NCOA6, NCOR2, NFKB1, NFKB2, NFKBIA, NFKBIB, NFKBIE, NKRF, NKX2-1, NOTCH1, NR3C1, NSD1, PARP1, PDLIM2, PGR, PIAS3, PML, POU2F1, PPARA, PPP1R13L, PPP2CA, PPP2CB, PPP4C, PRKCZ, REL, RELA, RELB, RFC1, RNF25, RXRA, SOCS1, SP1, SRF, STAT3, TAF1, TAF11, TAF4B, TAF6, TBK1, TBP, TERT, TLE1, TNIP2, TRIB3, TWIST1, UBC, UNC5CL
Description of target
p65 is a subunit of the nuclear factor kappa-B, a second messenger, which activates the transcription of a number of genes in multiple tissues. The inhibitory effect of I-kappa-B upon NF-kappa-B in the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. NFKB1 (MIM 164011) or NFKB2 (MIM 164012) is bound to REL (MIM 164910), RELA, or RELB (MIM 604758) to form the NFKB complex. The p50 (NFKB1)/p65 (RELA) heterodimer is the most abundant form of NFKB. The NFKB complex is inhibited by I-kappa-B proteins (NFKBIA, MIM 164008 or NFKBIB, MIM 604495), which inactivate NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B proteins by kinases (IKBKA, MIM 600664, or IKBKB, MIM 603258) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NFKB complex. Activated NFKB complex translocates into the nucleus and binds DNA at kappa-B-binding motifs such as 5-prime GGGRNNYYCC 3-prime or 5-prime HGGARNYYCC 3-prime (where H is A, C, or T; R is an A or G purine; and Y is a C or T pyrimidine).[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-1760 M62399.1 8-1767

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close